Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Total Current Liabilities (2017 - 2021)

Historic Total Current Liabilities for Cogent Biosciences (COGT) over the last 5 years, with Q3 2021 value amounting to $16.7 million.

  • Cogent Biosciences' Total Current Liabilities fell 1695.74% to $16.7 million in Q3 2021 from the same period last year, while for Sep 2021 it was $16.7 million, marking a year-over-year decrease of 1695.74%. This contributed to the annual value of $13.1 million for FY2020, which is 116.24% down from last year.
  • Cogent Biosciences' Total Current Liabilities amounted to $16.7 million in Q3 2021, which was down 1695.74% from $13.7 million recorded in Q2 2021.
  • Cogent Biosciences' 5-year Total Current Liabilities high stood at $26.4 million for Q3 2018, and its period low was $8.2 million during Q1 2021.
  • Over the past 5 years, Cogent Biosciences' median Total Current Liabilities value was $18.4 million (recorded in 2020), while the average stood at $18.0 million.
  • As far as peak fluctuations go, Cogent Biosciences' Total Current Liabilities surged by 12292.23% in 2018, and later plummeted by 6598.1% in 2020.
  • Cogent Biosciences' Total Current Liabilities (Quarter) stood at $11.2 million in 2017, then soared by 122.92% to $24.9 million in 2018, then tumbled by 46.89% to $13.2 million in 2019, then decreased by 1.16% to $13.1 million in 2020, then increased by 27.61% to $16.7 million in 2021.
  • Its last three reported values are $16.7 million in Q3 2021, $13.7 million for Q2 2021, and $8.2 million during Q1 2021.